Diversity, Equity & Inclusion

Implicit Bias in Life Sciences IP: How to Promote and Implement Bias-Reducing Strategies

September 21, 2022 3:00pm

Robin Evans
Deputy Commissioner for Patents
United States Patent and Trademark Office

Jamie L. Lucia
Partner
Steptoe & Johnson LLP

Linda Friedlieb
Division Counsel
AbbVie

Implicit bias refers to the unconscious attitudes or stereotypes that affect our understanding, actions, and decisions. In this interactive session, our panelists will introduce the topic of implicit bias in pharmaceutical patent litigation, share bias-reducing strategies, and will invite attendees to share their thoughts and perceptions on implicit bias. Topics of discussion will include:

  • Analyzing both involuntary and voluntary behaviors that hinder diversity, recruiting, and retention efforts in life sciences IP careers
  • Understanding the economic and other costs of implicit bias, especially in areas of law, science, IP, and innovation
  • Recommending strategies for reducing or eliminating bias
    • Identifying tests designed to aid in determining where biases exist